Eisai Receives Regulatory Review Outcome For Lecanemab As A Treatment For Early Alzheimer's Disease In Australia
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia TOKY ...
StudyFinds on MSN5h
Gamma stimulation for Alzheimer’s patients: 40-hertz sensory therapy shows tremendous promise
Researchers at MIT have discovered that exposing the brain to light and sound pulses at a specific frequency—40 hertz, or 40 cycles per second—can induce brain rhythms that reduce the hallmark ...
GB News on MSN7h
Alzheimer's breakthrough: Scientists discover why women more at risk of developing dementia than men
Scientists have discovered why women are more at risk of developing dementia than men in a new breakthrough for Alzheimer’s ...
Biogen (BIIB) Receives a Hold from Piper Sandler
In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...